TOPPAN and Dai Nippon Toryo Sign Licensing Agreement for Exosome Detection Technique Using TOPPAN’s Immunochromatography Technologies to Detect Exosomes and Contribute to the Development of Diagnostic Pharmaceuticals and Preventive Medicine

On October 19, 2023, TOPPAN Inc. (TOPPAN), a TOPPAN Group company and wholly owned subsidiary of TOPPAN Holdings (TYO: 7911), and Dai Nippon Toryo Co., Ltd. (TYO: 4611) (DNT) announced that they have executed a patent licensing agreement for the use of TOPPAN’s extracellular vesicle (exosome) detection technology using immunochromatography. The agreement provides a non-exclusive license to use the patent for TOPPAN’s technology in the design, development, fabrication, and sale of DNT’s Exorapid-qIC™ Immunochromatography Kit for Extracellular Vesicles. TOPPAN hopes the use of its technology will contribute to advancing techniques for early diagnosis and preventive medicine. DNT exhibited Exorapid-qIC™ for the first time at a booth at the 10th Academic Meeting of the Japanese Society for Extracellular Vesicles, which was held on October 23 and 24.

Login Or Register To Read Full Story